But preterm infants are more likely to be infected with E. Coli
The Group B Streptococcus is still the most common cause of bacterial meningitis in newborns, concludes a seven-year French study in the March issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Group B strep remains predominant despite the recent introduction of GBS screening for women near delivery, according to the new report, led by Dr. Jean Gaschignard Hôpital Antoine-Béclère, Clamart, France. However, the situation is different for preterm infants—who are at higher risk of death, regardless of the cause of their meningitis.
Largest-Ever Study of Newborn Bacterial Meningitis
Drawing on information from 60 percent of French pediatric wards from 2001 through 2007, the researchers identified 444 infants who were diagnosed with bacterial meningitis during the first 28 days of life. About two-thirds of cases were "late onset," occurring at least five days after birth. The remaining one-third were "early onset," occurring in the first four days (usually the first day).
The most common cause was GBS, which accounted for nearly 60 percent of cases. The next most common, about 30 percent, was Escherichia coli (E. coli)—a type of intestinal bacteria. In early-onset meningitis, GBS was even more common, accounting for more than three-fourths of cases. Infants who had seizures were also more likely to be infected with GBS.
The exception was preterm infants, who were more likely to be infected with E. coli: 45 percent of cases, compared to 32 percent for GBS. The rate of E. coli infection was even higher, 54 percent, in very preterm infants.
Overall, 13 percent of newborns with bacterial meningitis died. For preterm infants or those who were small for gestational age, the mortality rate increased to 25 percent.
The cooperative study was performed by the Pediatric Infectious Diseases Group of the French Pediatric Society to gain insights into the rates, causes, treatment, and outcomes of newborn bacterial meningitis in France. Over the past decade, hospitals in France and other developed countries began giving preventive antibiotics during the last weeks of pregnancy (intrapartum antibiotic prophylaxis) to mothers colonized with GBS.
This raised concerns that other causes of bacterial meningitis might become more common, or that meningitis caused by GBS might shift from early-onset to late-onset cases. "Nevertheless, at the dawn of the 21st century, GBS remains the dominant cause of neonatal bacterial meningitis in developed countries such as France," Dr. Gaschignard and co-authors write.
This study is the largest series of newborn bacterial meningitis cases ever published. "Despite this high number of reported cases, it is likely that the incidence of bacterial neonatal [newborn] meningitis remains underestimated," according to the authors. The 13 percent mortality rate is consistent with previous studies.
However, the risk of death is about twice as high in preterm infants. Because testing for GBS isn't usually performed until the thirty-fifth week of pregnancy, the "vast majority" of preterm infants aren't screened for GBS before birth. The researchers speculate that the higher rate of E. coli meningitis in premature infants might be partly related to their high rate of antibiotic intrapartum treatment—including amoxicillin, which kills GBS—before delivery.
About The Pediatric Infectious Disease Journal
The Pediatric Infectious Disease Journal® is a peer-reviewed, multidisciplinary journal directed to physicians and other health care professionals who manage infectious diseases of childhood. The journal delivers the latest insights on all aspects of infectious disease in children, from state-of-art diagnostic techniques to the most effective drug therapies and other essential treatment protocols. The Pediatric Infectious Disease Journal is official journal of the Pediatric Infectious Diseases Society and the European Society for Paediatric Infectious Diseases.
About Lippincott Williams & Wilkins
Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.
LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools, journals, and textbooks, such as Lippincott Williams & Wilkins; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons® and ProVation® Medical.